Functional Monitoring after Trabeculectomy or XEN Microstent Implantation Using Spectral Domain Optical Coherence Tomography and Visual Field Indices-A Retrospective Comparative Cohort Study.
glaucoma surgery
optical coherence tomography
primary open-angle glaucoma
standard automated perimetry
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
27 Mar 2021
27 Mar 2021
Historique:
received:
01
03
2021
revised:
20
03
2021
accepted:
23
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
The aim of this study was to compare the efficacy of trabeculectomy (TE), single XEN microstent implantation (solo XEN) or combined XEN implantation and cataract surgery (combined XEN) in primary open-angle glaucoma cases, naïve to prior surgical treatment, using a monocentric retrospective comparative cohort study. Intraocular pressure (IOP) and the number of IOP-lowering drugs (Meds) were monitored during the first 24 months after surgery. Further disease progression was monitored using peripapillary retinal nerve fiber layer (RNFL) thickness examinations using spectral domain optical coherence tomography (OCT) as well as visual acuity (VA) and visual field (VF) tests. In the TE group (52 eyes), the mean IOP decreased from 24.9 ± 5.9 to 13.9 ± 4.2 mmHg (
Identifiants
pubmed: 33801601
pii: biology10040273
doi: 10.3390/biology10040273
pmc: PMC8065996
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ophthalmology. 2007 Dec;114(12):2252-8
pubmed: 17466378
Clin Ophthalmol. 2020 Jun 30;14:1805-1832
pubmed: 32636610
Br J Ophthalmol. 2020 Aug;104(8):1125-1130
pubmed: 31727624
J Cataract Refract Surg. 2015 Sep;41(9):1905-9
pubmed: 26482822
World Med J. 1964 Sep;11:281
pubmed: 14182999
J Glaucoma. 2018 Feb;27(2):140-147
pubmed: 29271806
Bull World Health Organ. 1995;73(1):115-21
pubmed: 7704921
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Eye (Lond). 2019 Mar;33(3):469-477
pubmed: 30356133
Eur J Ophthalmol. 2020 Sep;30(5):1034-1041
pubmed: 31018685
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):983-996
pubmed: 30758653
Ophthalmology. 2013 Dec;120(12):2532-2539
pubmed: 24070811
J Glaucoma. 2019 Jan;28(1):75-79
pubmed: 30461555
Acta Ophthalmol. 2020 Sep 15;:
pubmed: 32930515
Sci Rep. 2020 Mar 11;10(1):4527
pubmed: 32161332
Acta Ophthalmol. 2019 May;97(3):e349-e355
pubmed: 30790460
Prog Brain Res. 2015;220:37-57
pubmed: 26497784
Ophthalmology. 2017 Nov;124(11):1579-1588
pubmed: 28601250
Sci Rep. 2020 Feb 18;10(1):2808
pubmed: 32071369
Eye (Lond). 2020 Mar;34(3):562-571
pubmed: 31409906
Am J Ophthalmol. 2015 Jun;159(6):1082-91
pubmed: 25748577
Arch Ophthalmol. 2003 Jan;121(1):48-56
pubmed: 12523884
Eye (Lond). 2002 May;16(3):297-303
pubmed: 12032721
Eye (Lond). 2001 Aug;15(Pt 4):441-8
pubmed: 11767016
Br J Ophthalmol. 2006 Jan;90(1):44-7
pubmed: 16361666
Am J Ophthalmol. 2013 Apr;155(4):674-680, 680.e1
pubmed: 23246272
Ophthalmology. 2008 Jan;115(1):85-93
pubmed: 17629563
Exp Eye Res. 2009 Apr;88(4):769-75
pubmed: 19114037
J Ocul Pharmacol Ther. 2015 Mar;31(2):63-77
pubmed: 25587905
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Clin Exp Ophthalmol. 2019 Jul;47(5):581-587
pubmed: 30578661
Optom Vis Sci. 2011 Jan;88(1):E39-47
pubmed: 21131879
Ophthalmology. 2006 Jun;113(6):930-6
pubmed: 16647135
Aust N Z J Ophthalmol. 1995 May;23(2):85-91
pubmed: 7546696
PLoS One. 2017 Aug 29;12(8):e0183142
pubmed: 28850575
Eye (Lond). 2012 Aug;26(8):1131-7
pubmed: 22722487
Sci Rep. 2019 Sep 25;9(1):13901
pubmed: 31554879
BMC Ophthalmol. 2020 Dec 17;20(1):490
pubmed: 33334311
J Glaucoma. 2017 Dec;26(12):1130-1136
pubmed: 29035911
Sci Rep. 2020 Nov 9;10(1):19337
pubmed: 33168873
Arch Ophthalmol. 2002 Oct;120(10):1268-79
pubmed: 12365904
J Ophthalmol. 2017;2017:5457246
pubmed: 28348884
Ophthalmol Glaucoma. 2020 Jan-Feb;3(1):32-39
pubmed: 32632405
Am J Ophthalmol. 2017 Nov;183:25-36
pubmed: 28784554
Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1227-1236
pubmed: 32140925